The Warburg Effect Is Associated With Tumor Aggressiveness in Testicular Germ Cell Tumors

Murilo Bonatelli1, Eduardo C A Silva2, Flavio M Cárcano3,4

  • 1Molecular Oncology Research Center, Barretos Cancer Hospital, São Paulo, Brazil.

Insights

Testicular germ cell tumors show altered metabolism, with increased glucose transporter 1 (GLUT1) and CD44 expression. These metabolic changes are linked to aggressive tumor characteristics and recurrence risk in patients.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Molecular Pathology

Background:

  • Testicular germ cell tumors (TGCTs) are the most common malignancy in young men, often responding to chemotherapy but sometimes showing treatment resistance.
  • Cancer cells exhibit altered energy metabolism (Warburg effect), overexpressing proteins involved in glycolysis and pH regulation.
  • The metabolic profile of TGCTs is underexplored, yet metabolic rewiring is linked to aggressive tumor behavior.

Purpose of the Study:

  • To investigate the prognostic value of key metabolism-related proteins in TGCTs.
  • To analyze the expression of glucose transporter 1 (GLUT1), carbonic anhydrase IX (CAIX), hexokinase II (HKII), lactate dehydrogenase V (LDHV), and CD44 in TGCTs.
  • To correlate protein expression with clinicopathological parameters and patient outcomes.

Main Methods:

  • Immunohistochemical analysis of GLUT1, CAIX, HKII, LDHV, and CD44 in 148 TGCT samples and paired normal tissues.
  • Categorization of tumors into 75 seminomas and 73 non-seminomas.
  • Statistical association of protein expression with clinicopathological features like staging, histology, and recurrence.

Main Results:

  • GLUT1 and CD44 expression were significantly elevated in TGCTs compared to normal tissues.
  • HKII and LDHV expression were significantly decreased in malignant samples.
  • CAIX expression correlated with disease recurrence, and HKII expression was associated with higher tumor stage and non-seminoma histology.

Conclusions:

  • TGCTs display altered expression of Warburg effect-related proteins, indicating a hyper-glycolytic phenotype.
  • The expression of CAIX and HKII serves as potential prognostic markers for TGCTs.
  • These findings offer new insights into the metabolic landscape of TGCTs and their association with aggressive disease characteristics.

Related Concept Videos

Aggression01:47

Aggression

Humans engage in aggression when they seek to cause harm or pain to another person. Aggression takes two forms depending on one’s motives: hostile or instrumental. Hostile aggression is motivated by feelings of anger with intent to cause pain; a fight in a bar with a stranger is an example of hostile aggression. In contrast, instrumental aggression is motivated by achieving a goal and does not necessarily involve intent to cause pain (Berkowitz, 1993); a contract killer who murders for...
30.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.9K